PIK3CA and cancer: Consistent with this view, Rudd et al., (Rudd et al., 2011) reported that half (29 of 58) of non-synonymous PIK3CA mutations in Type I and Type II cancers are located in exons 1–7 while half are in exons 9 and 20 (i.e., known hotspot mutations).